Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - OTHER CURRENT LIABILITIES
Other Current Liabilities SLS - SELLAS Life Sciences Group, Inc.
7.65 M
LAST VALUE
76.99%
2 YEAR CAGR
28.09%
5 YEAR CAGR
-18.28%
10 YEAR CAGR